personalized drug trials Personalized medicine
screening of thousands
screening settings
single-cell image analysis
drug responses
drug discovery
clinical data
approach
screening of anti-inflammatory properties of compounds
individualâ€™s peripheral blood
concrete clinical setting
single cell analysis of human liquid tissues
peripheral blood cells
retrospective trials
unique image
distinct sub-population specific cell cytotoxicity profiles of clinical anti-neoplastic agents
method pharmacoscopy
attention of potential investors
breaking resistance of hematological malignancies
broad spectrum of hematological disorders
ERC grant project plan
automated microscopy
primary myelofibrosis
oncologists
small samples
patient treatment
optimal therapy
lymphoma
tracking of fluorescent antibodies
therapeutic decision-making capability of hema
results
immune modulating drugs
bone marrow
possibility
current methodology
Chemical Hematology
know-how
test diseases
individuals
physiological relevance
information package attractive
probes
chemos
service
intellectual property rights
commercialization efforts
quest
robust manner
course
mind
funding